Dexamethasone and MicroRNA-204 Inhibit Corneal Neovascularization

Xiaoping Zhang1, Gang Wang2, Qing Wang1

  • 1Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266002, China.

Military Medicine
|August 31, 2022
PubMed
Abstract

Insights

Dexamethasone (Dex) may reduce corneal neovascularization (CNV) by increasing microRNA-204 (miR-204). This study found miR-204 inhibits cell migration and tube formation, suggesting it is a therapeutic target for alkali burn-induced CNV.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Pharmacology

Background:

  • Corneal neovascularization (CNV) is a significant cause of vision impairment.
  • Alkali burns are a common cause of severe ocular surface injury leading to CNV.
  • Dexamethasone (Dex) is a corticosteroid used to treat ocular inflammation, but its precise mechanism in CNV is not fully understood.

Purpose of the Study:

  • To investigate the interaction between dexamethasone (Dex) and microRNA-204 (miR-204) in a mouse model of alkali burn-induced corneal neovascularization (CNV).
  • To elucidate the functional role of miR-204 in human mammary epithelial cells (HMECs) in vitro.
  • To explore miR-204 as a potential therapeutic target for CNV.

Main Methods:

  • Established a corneal alkali burn model in BLAB/c mice.
  • Administered subconjunctival injections of Dex, negative control (NTC), or miR-204 agomir.
  • Quantified CNV area using immunofluorescence staining and miR-204 expression via qRT-PCR.
  • Assessed HMEC migration and tube formation in vitro after miR-204 modulation.

Main Results:

  • Alkali burn significantly reduced miR-204 expression.
  • Dex treatment upregulated miR-204 expression and reduced CNV area.
  • miR-204 agomir significantly inhibited HMEC migration and tube formation in vitro.
  • miR-204 antagomir demonstrated opposite effects, accelerating HMEC tube formation.

Conclusions:

  • Dexamethasone's anti-CNV effect is partly mediated by the upregulation of miR-204.
  • MicroRNA-204 plays an inhibitory role in corneal neovascularization.
  • miR-204 represents a promising therapeutic target for managing alkali burn-induced CNV.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
632